Form Type: 4

SEC EDGAR Link
Acccession Number:0001765581-19-000086
Date:2019-08-12
Issuer: JAZZ PHARMACEUTICALS PLC (JAZZ)
Original Submission Date:

Reporting Person:

TREACY PAUL
5TH FL, WATERLOO EXCHANGE
WATERLOO RD DUBLIN 4, L2

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2019-08-12 S 4,371 d $137.40 16,418 direct
ORDINARY SHARES 0 $0.00 106 indirect f3
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $137.4015 to $137.4322, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
f2 includes 140 ordinary shares acquired under a section 423 employee stock purchase plan on may 31, 2019.
f3 represents ordinary shares purchased by irish pensions trust limited, as trustee for and on behalf of the reporting person, as sole beneficiary, pursuant to an irish revenue approved profit share scheme on march 15, 2019 in a transaction exempt under rule 16b-3(c).

Elevate your investments